Biotech Lock Up Expiration Hell Portfolio: Wave II Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock Up Expiration Hell Portfolio: Wave II

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: michael_f_murphy who wrote (12)	4/8/2004 3:53:43 PM
From: keokalani'nui	Read Replies (1) of 107

Corcept Therapeutics (CORT: news, chart, profile) plans to offer 5 million shares at $15 to $17 each in a bid to raise up to $85 million with underwriter US Bancorp Piper Jaffray. Also, Immunicon Corp. (IMMC: news, chart, profile) plans to offer 6 million shares at $12 to $14 each in a bid to raise up to $84 million with underwriter UBS. The IPOs are attempting to debut after Memory Pharma (MEMY: news, chart, profile) rang up a hefty gain after the company cut its IPO price to $7 per share. Memory Pharma stock fell 45 cents to $9.20 on Thursday.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next